All posts by imreal

Universal Software Solutions partners with Virtue Technologies to offer best in class logistics technology solution


News Image

“We look forward to leveraging our expertise and applying it to Universal Software Solutions’ business,” says Gibran Ameer, Chief Executive Officer of Virtue Technologies.

Virtue Technologies, a leading provider of home infusion, specialty pharmacy, long term care pharmacy, and durable medical equipment logistics technology solutions, announced today a partnership with healthcare technologies solutions provider Universal Software Solutions. The partnership will enable Universal to offer VirtueScript, Virtue Technologies’ logistics technology solution, to its clients. The solution automates delivery workflow processes and increase the level of communication that occurs across the continuum of post-acute care.

“We are very pleased to enter into this partnership with Virtue Technologies. This partnership will allow the Universal Software Solutions software platform (HDMS) to leverage leading edge technology related to delivery management, tracking, and delivery documentation for the industry, allowing our customers to better manage resources internally,” says Richard van der Lek, Vice President Applications of Universal Software Solutions.

“Our partnership with Universal Software Solutions allows us to further execute upon our vision of taking an agnostic, interoperable approach to healthcare technology solutions. Our goal is to reduce friction and offer automation as it relates to delivery management in the post-acute market,” says Gibran Ameer, Chief Executive Officer of Virtue Technologies. “We look forward to leveraging our expertise and applying it to Universal Software Solutions’ business.”

# # # #

About Virtue Technologies

Virtue Technologies is a provider of cloud-based software committed to solving the challenges of the highly fragmented durable medical equipment and pharmacy markets. The solutions strive to drive out cost and improve the revenue cycle by improving staff efficiency, removing waste, increasing patient satisfaction, and providing unparalleled visibility to pharmacy operations. In an environment of shrinking reimbursements, growing audit risk, and persistent demand from patients and caregivers, Virtue Technologies provides the solutions the market demands.

About Universal Software Solutions

Universal Software Solutions was founded on January 1st, 2000, in response to a demand in the market for an automated data management solution. The goal was to provide operation efficiencies in a barrier-free environment with flexibility and scalability. Universal prides itself on creating products built on a nimble and sophisticated database structure that allows providers in the post-acute healthcare market to provide exemplary patient with lean resources. Universal has been a privately held company with consistent leadership & product visionaries since inception. After twenty plus years of providing a dependable solution to America’s top post acute-care healthcare providers, the desire and focused vision of Universal ensures another twenty plus. The Universal Team is comprised of unique and talented software professionals specializing in product engineering, software education, and customer service based in Davison, Michigan; all of whom go above and beyond for clients every day. With Universal, it’s personal.

Share article on social media or email:

Iscential and Members1st Insurance Services Powered by Iscential Ready to Help with Medicare and National Open Enrollment


News Image

It’s that time of year again! Open enrollment for health insurance is beginning. If you’re looking for individual health insurance, family health insurance, or Medicare, Iscential and Members1st Insurance Services Powered by Iscential can help you get coverage.

Iscential and Members1st Insurance Services Powered by Iscential Ready to Help with Medicare and National Open Enrollment!

It’s that time of year again! Open enrollment for health insurance is beginning. If you’re looking for individual health insurance, family health insurance, or Medicare, Iscential and Members1st Insurance Services Powered by Iscential can help you get coverage.

As we approach the National Open Enrollment period for the Affordable Care Act medical plans, we are available to help with the application process from November 1st through December 15th (for plans with an effective date of January 1, 2023).

However, we are also available all year to help with coverage for medical (no qualified life event required) AND many other coverages not offered through the ACA open enrollment:

  • Dental
  • Vision
  • Life insurance
  • Disability
  • Long-term care
  • Accident
  • Critical illness
  • Cancer
  • Hospital Indemnity
  • International Medical plans
  • Travel Insurance
  • HSA

For individual and family health insurance, our Benefits Advisors will provide a free consultation at no obligation to you – just contact us at benefitservices@iscential.com or (713) 856-5533 to get started!

For Medicare visit: Members 1st Insurance (office365.com) to book an appointment with one of our advisors.

Share article on social media or email:

AmeriCare Medical Acquires QCN Home Health Care, Starts Admitting Medicare Patients


News Image

“Having a Medicare-certified home care agency allows us the opportunity to care for even more people needing home care services,” stated Greg Jamian, AmeriCare Medical President and CEO.

AmeriCare acquired QCN Home Health Care to expand its line of home healthcare businesses by now being able to offer in-home services to Medicare recipients. “Having a Medicare-certified home care agency allows us the opportunity to care for even more people needing home care services,” stated Greg Jamian, AmeriCare Medical President and CEO. “Studies have shown that individuals who are ill or injured prefer to recover in the privacy and comfort of their home, and QCN joins our network of companies that provide fully integrated home care services to the aging population.” Jamian also noted and further commented that, “the hospital to home industry expects a Compound Annual Growth Rate (CAGR) of 8% from 2022 to 2030, further fueling the demand for our services.”

AmeriCare Medical’s collection of companies includes AmeriStaff Nursing Services, a private-duty home care agency that offers nursing services in the home and to facilities, Sun Medical Equipment and Supply, serving the Metro Detroit area with three retail locations, which also delivers physician-prescribed products right to the home, and Rx iV Specialty Pharmacy, which provides home infusion and intravenous therapy services.

Maggie Jess, AmeriCare’s Director of Nursing added, “QCN has stood for Quality Compassionate Nursing for over 20 years and our highly trained staff will provide a seamless transition to post-acute recovery from skilled nursing to physical therapy. We are the best choice for managing all your home care needs.”

AmeriCare Medical, Inc. is a locally owned and operated company that provides integrated healthcare solutions to hospitals, assisted care facilities, and private homes throughout Michigan. AmeriCare Medical, Inc. now has six divisions that include: QCN, AmeriStaff Nursing Services, Sun Medical Equipment, Private Reserve Home Care, Rx iV Infusion Pharmacy, and Oak Bridge Case Management. AmeriCare Medical provides dignity and serenity for the family and patient by offering the convenience of an “all-inclusive experience” for a patient’s home healthcare needs.

For more information visit: http://www.americaremedical.com

###

Share article on social media or email:

Carrie Tompkins Stricker, PhD, RN, ANP-BC, CRNP, Receives APSHO Award for Excellence in Oncology Advanced Practice


Carrie’s unrelenting innovation, exemplary leadership, patient-outcome–focused research, interdisciplinary collaboration, mentorship, and dedication to advancing the AP role exemplifies excellence.

The Advanced Practitioner Society for Hematology and Oncology (APSHO) presented the fifth annual Mary Pazdur Award for Excellence in Advanced Practice in Oncology to Carrie Tompkins Stricker, PhD, RN, ANP-BC, CRNP, an associate professor at Thomas Jefferson University College of Nursing. Created in honor of the late Mary Pazdur, RN, MSN, the award is presented to an advanced practitioner and member of APSHO who consistently demonstrates exemplary leadership and outstanding contributions to clinical practice, research, and education in the oncology/hematology field.

A charter member of APSHO, Dr. Stricker is the founding director of Thomas Jefferson University College of Nursing’s graduate program in Transformative Systems Leadership and an entrepreneur, health services researcher, and clinician. In 2013, she co-founded Carevive Systems, Inc., whose EMR-integrated cancer care digital platform enables evidence-based cancer care management and patient engagement to improve clinical outcomes. As chief clinical officer, Dr. Stricker saw Carevive’s oncology solutions widely adopted and integrated for clinical and research use, and then expanded to include computerized algorithms for symptom management decision support.

Despite her many pursuits outside of the clinic, “Carrie has unerringly demonstrated her deep commitment to patient care by retaining an active practice as an oncology nurse practitioner,” said Deborah Mayer, PhD, RN, AOCN®, FAAN, of UNC Lineberger Comprehensive Cancer Center in Chapel Hill, North Carolina. In her recommendation letter, Dr. Mayer cited the 2010 memoir of U.S. Senator (PA) Arlen Specter, Never Give In: Battling Cancer in the Senate, wherein he mentioned Dr. Stricker’s “keen awareness of the psychological dimension of the cancer experience.”

The award ceremony took place during JADPRO Live, an annual educational event during which the APSHO annual meeting takes place. The conference welcomes more than 1,000 attendees annually, including oncology/hematology nurse practitioners, physician assistants, pharmacists, and other advanced degree nurses and health-care professionals. Past recipients of the award include Jody Pelusi, PhD, FNP, AOCNP®, of HonorHealth Research Institute in Scottsdale, Arizona; Jeannine Brant, PhD, APRN, AOCN®, FAAN, of City of Hope Comprehensive Cancer Center in Duarte, California; Christina Cone, DNP, APRN, ANP-BC, AOCNP®, of Duke Cancer Institute, Durham, North Carolina; and Allyson Price, PA-C, Thought Leader Liaison for AbbVie.

To learn more about the Mary Pazdur Award, please visit marypazduraward.com.

About JADPRO Live

JADPRO Live is a medical conference inspired by the Journal of the Advanced Practitioner in Oncology. This year’s meeting took place from October 20 through October 23 in Aurora, Colorado.

About APSHO

The Advanced Practitioner Society for Hematology and Oncology (APSHO) is a society of nearly 4,000 oncology advanced practitioners, including nurse practitioners, physician assistants, pharmacists, clinical nurse specialists, and other health-care professionals. The mission of APSHO is to promote oncology patient care that is high quality, cost effective, and delivered through collaborative practice models by optimizing the role of the advanced practitioner as an integral member of the care team.

Dr. Stricker is also the executive director of Canopy Cancer Collective, a learning health network of 14 NCI-designated cancer centers, dedicated to improving care and patient-defined quality survival for pancreatic cancer. In addition to her other roles, she is the president and founder of Accelerate Outcomes, LLC, a consulting company that provides expertise in all areas of health care and health technology for health system and corporate clients who want to improve their capacity and funding support to drive high quality outcomes.

Known for her oncology supportive care expertise as an oncology nurse practitioner, Dr. Stricker is respected for her leadership in using digital health and care delivery innovation to transform cancer care. “Carrie Stricker embodies the focus of the Mary Pazdur Award for Excellence in Advanced Practice in Oncology in so many ways,” said APSHO Board of Directors President Sandra Kurtin, PhD, ANP-C, AOCN®, FAPO, from the Arizona Cancer Center at the University of Arizona. “Carrie’s unrelenting innovation, exemplary leadership, patient-outcome–focused research, interdisciplinary collaboration, mentorship, and dedication to advancing the AP role exemplifies excellence.”

Former colleagues describe a supportive and driven partner when talking about Dr. Stricker. After joining the CT Challenge Survivorship Network’s Medical Advisory Board, where she advised on state-wide development of cancer survivorship programs and services, “she enhanced both the visibility and impact of oncology nurses and advanced practitioners in our state…in both community-based and academic settings,” said Andrew Salner, MD, FACR, of the Hartford Healthcare Cancer Institute at Hartford Hospital in Connecticut.

Adfinitas Health Announces New Medical Director at University of Maryland Capital Region Medical Center


Adfinitas Health, a Maryland-based provider of acute and post-acute clinical care, announces the new medical director at the University of Maryland Capital Region Medical Center, Lee-Ann Wagner. Lee-Ann is well-respected in the Baltimore medical community, has a broad background, and, with her strong ties to the University of Maryland Medical Center and experience within the University of Maryland System, she is an incredible asset to the Adfinitas team.

“When you meet Lee-Ann you quickly realize her passion for quality improvement and great love for hospital medicine,” says Doug Mitchell, founder and chief executive officer of Adfintas Health. “She is very dedicated to the growth of this profession as she strives to find ways to optimize work for physicans ensuring the best care for patients is provided while hospitals are reimbursed appropriately.”

Lee-Ann’s broad background includes time as an Assistant Professor at the University of Maryland School of Medicine and providing inpatient services leadership. As a physician, she combines scientific strategic analysis and compassionate care. She is a proven creative problem solver who enjoys building something from the ground up. “This position, as part of the Adfinitas team, is a culmination of my broad experience into one role which includes medical education, research guidance and mentorship”, said Lee-Ann Wagner, medical director University of Maryland Capital Region Medical Center. “The folks at Capital Region Medical Center are really passionate about building something great, and I am honored to be a part of that.”

UM Capital Region Medical Center is a state-of-the-art acute care teaching hospital supporting Prince George’s County and the surrounding areas. The Medical Center was designed from the ground up for patient safety and patient experience. Visit the hospital here:

https://www.umms.org/capital/about/future/um-capital-region-medical-center

About Adfinitas Health

Adfinitas Health is a trusted provider of compassionate clinical care across the entire continuum from acute to post-acute. We deliver innovative, customizable services and value-based, collaborative care to our partners with an unwavering commitment to client satisfaction. Adfinitas transforms patient care with fully engaged clinicians who become integral members of site-based teams, leading the clinical, administrative, and operational components of patient care. Founded in 2007 by board-certified physicians, Adfinitas Health partners with more than 65 hospitals and post-acute facilities across the US. We effectively recruit and employ highly-skilled physicians and advanced practice providers who provide expertise, leadership and advisory support to improve clinical care, quality, and operations. Adfinitas Health also provides industry leading training programs for advanced practice providers supporting strong retention and clinical performance. Please visit: https://www.adfinitashealth.com/

Share article on social media or email:

Blockchain Pioneer Brock Pierce Partners with Jeremy Gardner as a General Partner in Mystic Ventures


Jeremy Gardner and Brock Pierce on stage at Wonderland Psychedelic Convention in Miami

The industry is barely in its infancy. However, the potential reward to humanity, mental health, and those who get in on the ground floor, is immeasurable, said Pierce.

This week at the Wonderland Psychedelic Convention in Miami, Chairman of the Bitcoin Foundation, Economist, and Philanthropist Brock Pierce announced that he is partnering with Jeremy Gardner, the Managing Partner and Founder of Mystic Ventures, as a General Partner in this cutting-edge venture fund. Pierce is the co-founder of EOS Alliance, Block.one, Blockchain Capital, Tether, and Mastercoin, the sector’s first ICO. Gardner is the Founder of Blockchain Education Network, Co-founder of Augur, the world’s first Utility Token and first ICO on Ethereum.

Pierce has been a long supporter of MAPS, the Multidisciplinary Association for Psychedelic Studies. He is also a pre-IPO investor in ATAI Life Sciences, a Germany-based clinical-stage biopharmaceutical company. As an investor in Filament Health, a Canadian-based clinical-stage natural psychedelic development company, Pierce is a veteran in this important new sector.

Mystic is an AngelList Ventures Fund focused on the medicinal applications of psychedelics. Mystic Ventures functions like a biotech venture fund, oriented towards scientific breakthroughs and new applications of promising therapeutics and plant medicines. Mystic is dedicated to driving these advanced research and development teams, often from pharmaceutical companies and top research universities, to develop cost-effective solutions that are less exploitive, addictive, and focused on holistic healing rather than ongoing treatment. Mystic and their portfolio are working to make psychedelic medicines and therapies mainstream.

Mystic Ventures is a rolling fund on AngelList Ventures. It’s a standard 2:20 (management/carry) with a $25,000 minimum quarterly ticket size for a commitment of 8 quarters. The fund’s Investments range from AI-powered drug discovery to the development of new treatments, as well as far-ranging startups such as a breathwork app and biofeedback powered haptic sound startup.

About Brock Pierce

Brock Pierce is a blockchain pioneer, technology investor and philanthropist with an extensive track record of founding, advising, and investing in disruptive businesses. He’s been credited with pioneering the market for digital currency and has raised more than $5B for companies he has founded. Pierce is the Chairman of the Bitcoin Foundation and co-founder of EOS Alliance, Block.one, Blockchain Capital, Tether, Mastercoin (first ICO), and Lighthouse NFT, the first ground-up physical NFT smart gallery. In 2020, Pierce ran for President of the United States as an Independent, receiving the first-ever US presidential vote cast on the blockchain. Pierce is currently chairman of Percival, his business office which invests in public and private opportunities with a focus on early-stage investments in deep tech.

Block.one was co-founded by Pierce in 2017. Block.one has sold over $4B tokens in the EOS crowd sale making it the largest ever. Blockchain Capital was founded in 2013 and is the first sector-focused venture fund that invests solely in Blockchain technology companies. Pierce led the firm through the first ICO of a venture fund, which created the first security token, BCAP. Blockchain Capital has made more than 100 investments in the sector across its four funds. The firm was named the most active FinTech Venture Fund by Pitchbook. Tether, the first stable coin and asset-backed token, is the most traded cryptocurrency by volume.

Pierce is also a co-founder of D10e, GoCoin, the first cryptocurrency platform to fund a political campaign, Blade Payments, Five Delta (sold NASDAQ: SRAX), Xfire 2.0, Playsino, Evertune, and GamesTV. He serves as an advisor to a number of companies, including Airswap, Bancor, BitGo, BitGuild, Bloq, Element Group, Metronome, Shyft, tZERO, ODX and BlockV, the first NFT platform in the world. He is a General Partner in Space Fund and sits on the Board of Directors for Bit Digital, one of the largest cryptocurrency mining companies in the US.

He is an active supporter of the American Civil Liberties Union (ACLU), the Foundation for Individual Rights in Education, the Center for Individual Rights, and the Brennan Center for Human Rights. Pierce is Chairman of the Integro Foundation, a Puerto Rico-based non-profit focused on helping Puerto Ricans and supporting environmental and humanitarian efforts throughout the Caribbean region. Pierce is also Vice Chair of the U.S. Marines Toys for Tots Foundation of New York, Long Island and Puerto Rico. Pierce is a frequent lecturer at Singularity University and has spoken at the Milken Global Conference, Mobile World Congress, Wired, INK, Stanford University, USC, and UCLA.

Share article on social media or email:



Last Call to Sign Up for Virtual 5K from Wellness Solutions Company, GOLO


Sign up for GOLO Virtual 5K

Walk, run, or jog in the GOLO Virtual 5K

“We’re so proud of this event because it brings people of all ages, lifestyles, and backgrounds together for a fun and healthy activity,” says Jennifer Brooks, President and Co-founder of GOLO.

GOLO, the pioneering wellness solutions company, is bringing back its popular semi-annual GOLO Virtual 5K event. Scheduled for November 12 – 13, 2022, the GOLO Virtual 5K is free and open to the public.

GOLO Virtual 5K participants can compete at their own pace by either running, walking, or jogging. After completing the 5K, competitors can submit their results, route, and pictures to enter a special drawing to win GOLO prizes. Registration for the event closes on November 11, 2022. Click here to learn more and to sign up.

“We’re so proud of this event because it brings people of all ages, lifestyles, and backgrounds together for a fun and healthy activity,” says Jennifer Brooks, President and Co-founder of GOLO.

Headquartered in Newark, Delaware, GOLO empowers individuals and communities by helping them take control of their wellness goals. The semi-annual GOLO Virtual 5K reinforces the company’s ongoing commitment to supporting community-based health and wellness initiatives throughout the U.S.

About GOLO

GOLO® products provide safe solutions to weight-loss and wellness while helping individuals transition to a healthier and sustainable lifestyle. GOLO has reached over two million people worldwide who now have a chance at healthy, sustainable, and affordable weight loss. For more information about the GOLO® for Life plan, visit golo.com or call 800-730-4656.

###

Share article on social media or email:

Women We Admire Announces Top 50 Women Leaders in Medicine of 2022


Women We Admire is pleased to announce the Top 50 Women Leaders in Medicine of 2022. This group of individuals is comprised of physicians, doctors, clinicians and educators who are changing the face of medicine through their profession, teachings, and personal lives. We recognize and honor each awardee for their commitment to quality care and advancements within the field. Their initiatives and dedication have proven to be invaluable contributions to society, both locally and internationally.

Among this year’s awardees is Avril Beckford, Chief Pediatric Officer of WellStar Health System, whose passion in early childhood brain development and emotional intelligence has led her to be published in textbooks and within articles in medical journals and parenting & teaching publications. Awardee Mariam Bekhit, Chief Medical Officer of Hidden River Eating Disorder Treatment, is a passionate psychiatrist who treats patients with a combined psychotherapeutic and pharmacological intervention approach. Also awarded is Theresa Heah, Chief Medical Officer and President of Kriya Therapeutics, who is advancing the company’s ophthalmology gene therapies and overall portfolio through its in-house R&D and business development engines.

Please join us in recognizing the outstanding accomplishments of the Top 50 Women Leaders in Medicine of 2022.

Este Geraghty (Esri), Avril Beckford (WellStar Health System), Natalie Hartenbaum (OccuMedix), Mariam Bekhit (Hidden River Eating Disorder Treatment), Suzanna Fox (Atrium Health), Alice Lorch (Massachusetts Eye and Ear), Theresa Heah (Kriya Therapeutics), Stephanie Coyne (Veterans Administration), Jess Guarnaschelli (Medpace), Meera Wells (Hackensack Meridian Health), Aenor Sawyer (University of California; Skeletal Health Service UCSF Department Orthopaedic Surgery), Arshiya Seth (Cambridge Health Alliance), Arti Lakhani (AMITA Health), Theresa Pazionis (Temple Health – Temple University Health System), Sulin Chung (Envision Healthcare), Luxme Hariharan (Nicklaus Children’s Health System), Shanna Newbold (Vituity), Jamie Engel (Parkview Medical Center), Elana Oberstein (ModMed), Ilkcan Cokgor (MarinHealth), Annie Varughese (North Houston Family Medicine), Allyson Shrikhande (Pelvic Rehabilitation Medicine), Aarti Singla (Beacon Orthopaedics & Sports Medicine), Rohini Bogineni (Doctors Medical Center of Modesto), Melissa Rosenhan (Schweiger Dermatology Group), and many others.

To view the full list, visit https://thewomenweadmire.com/2022/11/07/top-50-women-leaders-in-medicine-of-2022/

About Women We Admire

Women We Admire provides news and information on today’s women leaders in business, entertainment, sports, motherhood, medicine, law, and many other fields. We cover a broad range of topics and areas of interest aimed at recognizing the achievements of exceptional women while inspiring others to aim high and continue their journey towards reaching their full potential. Women We Admire and its affiliates circulate its content to over 32,000 individuals and businesses.

Share article on social media or email:

AWKO Files Class Action Lawsuit Regarding Alleged Cancerous Hair Relaxing/Straightening Products


This is a pivotal moment for all of the women who trusted these companies and used their hair relaxers year after year based on the belief that they were safe to use.

On November 3, 2022, Aylstock, Witkin, Kreis & Overholtz, PLLC (“AWKO”) filed the first class action lawsuit against L’Oréal USA, Inc. and Softsheen-Carson, Inc. for alleged toxic and dangerous hair relaxers and/or straighteners that are directly marketed to women of color. These products contain hazardous endocrine disrupting chemicals and other toxins that are known to contribute to and/or cause devastating and irreversible injuries.

AWKO filed this class action lawsuit in response to recent studies finding that Black women who use hair relaxing products develop cancers, like uterine cancer, at a disproportionate rate as compared to White women. This is very troubling, as the corporations marketing these products specifically target Black women, as well as Black children, many of whom begin using these products at a young age. This lawsuit centers on consumer claims and a need for medical monitoring of all women who have used these products, particularly as the science underlying its horrible injuries develops and is examined more thoroughly.

Hannah Pfeifler, an associate at AWKO, stated: “This is a pivotal moment for all of the women who trusted these companies and used their hair relaxers year after year based on the belief that they were safe to use.”

For over 20 years, AWKO has been fighting for the rights of women who have suffered devastating, life-altering injuries from defective products and/or dangerous pharmaceutical drugs and medical devices, such as hormone replacement therapy drugs, talcum powder, and transvaginal mesh. AWKO is honored to continue fighting for women in this litigation.

United States District Court Northern District of Illinois Eastern Division

Case Number: 1:22-cv-06110

Share article on social media or email:

CDC Awards Funding for Mount Sinai World Trade Center (WTC) Health Program Clinical Center of Excellence


The ongoing support of the federal government ensures that we’re able to provide critically needed services to responders,” said Michael Crane, MD, MPH, Medical Director of the Selikoff Centers.

The National Institute for Occupational Safety and Health, part of the Centers for Disease Control and Prevention (CDC), has awarded new funding for the World Trade Center (WTC) Health Program Clinical Center of Excellence at the Icahn School of Medicine’s Department of Environmental Medicine and Public Health.

Under this new contract, which will fund up to $340 million over eight years, our WTC Health Program will continue to provide— at no cost—medical monitoring, treatment, and case management services for responders who participated in the rescue, recovery, debris clean-up, and related support services following the terrorist attacks on September 11, 2001. Our WTC Health Program, a component of the Mount Sinai Selikoff Centers for Occupational Health, is the largest such center in the country and proudly cares for more than 25,000 responders at its Manhattan, Staten Island, Suffern, and Yonkers, New York, locations.

“The ongoing support of the federal government ensures that we’re able to provide critically needed services to responders,” said Michael Crane, MD, MPH, Medical Director of the Selikoff Centers. “Decades after 9/11, we’re only beginning to understand the health effects related to exposure to the WTC disaster site. Thousands of responders have developed chronic physical and mental health conditions, and all of them require monitoring and dedicated, ongoing care. The terms of this contract underscore our WTC Health Program’s commitment to meet the expanding health care needs of our aging responder population, in areas including mental health, cancer care, and case management.”

Sandra M. Lowe, MD, Medical Director of the WTC Center’s Mental Health Program, added, “Many responders who developed psychiatric conditions due to their work at the WTC disaster site continue to experience symptoms, adding to their overall health burden. This funding will allow us to continue to address the growing mental health care needs of our program’s brave responders.”

About the Mount Sinai Health System

Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with more than 43,000 employees working across eight hospitals, over 400 outpatient practices, nearly 300 labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time — discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.

Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 7,300 primary and specialty care physicians; 13 joint-venture outpatient surgery centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and more than 30 affiliated community health centers. We are consistently ranked by U.S. News & World Report’s Best Hospitals, receiving high “Honor Roll” status, and are highly ranked: No. 1 in Geriatrics and top 20 in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Neurology/Neurosurgery, Orthopedics, Pulmonology/Lung Surgery, Rehabilitation, and Urology. New York Eye and Ear Infirmary of Mount Sinai is ranked No. 12 in Ophthalmology. U.S. News & World Report’s “Best Children’s Hospitals” ranks Mount Sinai Kravis Children’s Hospital among the country’s best in several pediatric specialties. The Icahn School of Medicine at Mount Sinai is one of three medical schools that have earned distinction by multiple indicators: It is consistently ranked in the top 20 by U.S. News & World Report’s “Best Medical Schools,” aligned with a U.S. News & World Report “Honor Roll” Hospital, and top 20 in the nation for National Institutes of Health funding and top 5 in the nation for numerous basic and clinical research areas. Newsweek’s “World’s Best Smart Hospitals” ranks The Mount Sinai Hospital as No. 1 in New York City and in the top five globally, and Mount Sinai Morningside in the top 30 globally; Newsweek also ranks The Mount Sinai Hospital highly in 11 specialties in “World’s Best Specialized Hospitals,” and in “America’s Best Physical Rehabilitation Centers.” For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter, and YouTube.

Share article on social media or email: